Developer docs
API playgroundTry for free, no card

Search company profiles

Evvy

Full company profile

uuid00002xr

Namestring
Evvy
Legal namestring
Evvy
Websiteurl
evvy.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Evvy is a New York-based precision women's health company that operates a direct-to-consumer platform anchored by the first and only CLIA/CAP/CLEP-certified at-home vaginal microbiome test. The flagship test uses metagenomic next-generation sequencing (mNGS) on a single self-collected swab to screen 700+ bacteria and fungi—versus 1–3 pathogens in standard OB-GYN testing—and is processed in Evvy's CLIA-certified lab with clinician-reviewed results, a personalized care plan, optional Rx treatment, and a free 1:1 health coaching session. The underlying AI/molecular signature discovery platform is built on what the company describes as the world's largest vaginal microbiome dataset (100,000+ samples) and was used to identify six distinct microbial subtypes of bacterial vaginosis that have been integrated into the test report and care pathway.

The company has expanded beyond the core diagnostic into a vertically integrated care stack. Product lines now include the UTI+ PCR urine test (12 uropathogens, 7 antibiotic resistance genes, 1-day results), a Women's Complete Probiotic with Evvy's proprietary Lactobacillus blend plus postbiotic, prescription vaginal suppositories (probiotic, boric acid, hyaluronic acid), hormone-related Rx products (Estradiol Vaginal Cream, anti-itch and soothing vulva creams), a Male Partner BV Treatment regimen, the multi-step Evvy Complete Treatment Program, and curated bundles. All Rx products are compounded at a 503a NABP-accredited pharmacy and prescribed by Evvy-affiliated providers via asynchronous telehealth.

Evvy monetizes through a hybrid one-time purchase plus subscription model. The flagship Vaginal Health Test is priced at $159 one-time or $129/test on a quarterly Evvy Membership (4 tests/year); the UTI+ Test is $248 one-time or $217.99 on quarterly subscription; probiotics, suppositories, and creams are priced $39–$69 with Subscribe & Save options delivering 10–20% discounts. Bundles (up to $348) drive AOV. Primary customer segments are women with recurrent vaginal symptoms, women on the fertility journey, women in perimenopause/menopause, and women with recurrent UTIs, supplemented by a smaller segment of male partners of women with recurrent BV. Distribution is entirely D2C through evvy.com with US-dominant reach and limited Canada availability; no third-party retail or enterprise channel is in use.

Short descriptiontext

Evvy is a New York-based precision women's health company that sells the first CLIA-certified metagenomic at-home vaginal microbiome test, plus companion diagnostics (UTI+), telehealth-prescribed Rx products, and probiotics, serving women with recurrent vaginal symptoms, fertility, menopause, and recurrent UTI needs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vaginal microbiome testing, at-home diagnostic tests, women's health platform, metagenomic sequencing services, prescription telehealth care
Industry3 codes
PRIMARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code4 codes
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Medical Laboratories621511
SIC code3 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Women's Health Diagnostics
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model6 records
1At-home Vaginal Health Test Sales
TypeOne Time License
Description

One-time and subscription sales of the flagship at-home Vaginal Microbiome Test at $159 one-time or $129/test on a quarterly membership (4 tests/year); includes Expanded PCR Panel add-on for +$89.

evvy.com
2Membership/Subscription Revenue
TypeSubscription Recurring
Description

Recurring Evvy Membership billing quarterly with auto-refills, providing discounted tests, continuous tracking of microbiome changes, free coaching, and subscription savings (~$30 per test). Skip or cancel anytime.

evvy.com
3UTI+ Test Sales
TypeOne Time License
Description

One-time and subscription sales of the at-home UTI+ PCR urine test at $248 one-time or $217.99 on quarterly subscription; eligible customers can purchase targeted Rx treatment separately after results.

evvy.com
4Probiotic & Supplement Sales
TypeSubscription Recurring
Description

Direct-to-consumer sales of Women's Complete Probiotic ($55 one-time or $44/month on Subscribe & Save with 20% off), Vaginal Probiotic Suppositories ($59 one-time or $47.20/every 2 months with 20% off).

evvy.com
5Prescription (Rx) Product Sales
TypeManaged Services
Description

Sales of compounded Rx products (Pure Boric Acid Suppositories $39, Hyaluronic Acid Suppositories $59, Estradiol Vaginal Cream $69, Anti-Itch Vulva Cream $59, Soothing Vulva Cream $59, Evvy Complete Treatment Program) prescribed by Evvy-affiliated providers, priced separately from tests and dispensed via 503a NABP-accredited pharmacy.

evvy.com
6Bundle Sales
TypeTransaction Fee
Description

Bundled product collections with 10-15% discounts: Vaginal Health & UTI+ Test Bundle ($348), Women's Probiotic Bundle ($97), Vaginal Health Test & Probiotic Bundle ($192.60), Vaginal Health Test 2-Pack ($258).

evvy.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Pricing details8 tiers
1Evvy Vaginal Health Test — single $159 or membership $129/test (quarterly)
ModelSubscriptionBilling cadenceAnnual
Notes

One-time purchase: $159. Subscribe & Save membership: $129/test, 4 tests/year shipped every 3 months (save $30/test). Expanded PCR Panel add-on +$89 (not available in NY). Free 1:1 coaching call included.

evvy.com
2Evvy UTI+ Test — single $248 or membership $217.99 (quarterly)
ModelSubscriptionBilling cadenceAnnual
Notes

One-time: $248. Subscribe & Save (4 tests/year, every 3 months): $217.99. Rx treatment sold separately after results. Not available in AK, HI, NY or Canada.

evvy.com
3Women's Complete Probiotic — single $55 or monthly $44 subscription
ModelSubscriptionBilling cadenceMonthly
Notes

One-time: $55. Subscribe & Save: $44/month (save 20%). 30 capsules (1 month supply). US only. HSA/FSA eligible. 30-day guarantee for first-time orders.

evvy.com
4Vaginal Probiotic Suppositories — single $59 or every-2-months $47.20 subscription
ModelSubscriptionBilling cadencePay-as-you-go
Notes

One-time: $59. Subscribe & Save (every 2 months, save 20%): $47.20. 20 suppositories. Rx product; requires clinical intake form.

evvy.com
5Pure Boric Acid Suppositories — single $39 or every-2-months $35.10 subscription
ModelSubscriptionBilling cadencePay-as-you-go
Notes

One-time: $39. Subscribe & Save (every 2 months, save 10%): $35.10. 12 suppositories. 600mg boric acid.

evvy.com
6Hyaluronic Acid Suppositories — single $59 or every-2-months $53.10 subscription
ModelSubscriptionBilling cadencePay-as-you-go
Notes

One-time: $59. Subscribe & Save (every 2 months, save 10%): $53.10. 12 suppositories, 5mg hyaluronic acid each.

evvy.com
7Rx Creams and Estradiol Vaginal Cream — $59-$69 each
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Estradiol Vaginal Cream $69, Anti-Itch Vulva Cream $59, Soothing Vulva Cream $59. All Rx products require clinical intake and are compounded at 503a NABP-accredited pharmacy.

evvy.com
8Bundled collections with 10-15% discounts from $97 to $348
ModelOtherBilling cadencePay-as-you-go
Notes

Vaginal Health & UTI+ Test Bundle $348 (save 15%, normally $407); Women's Probiotic Bundle $97 (save 15%); Vaginal Health Test & Probiotic Bundle $192.60 (save 10%); Vaginal Health Test 2-Pack $258 (save $60). Cannot be combined with additional discounts.

evvy.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 6 records shown
1Evvy Vaginal Health Test
Description

Evvy's flagship at-home CLIA-certified, mNGS vaginal microbiome test that screens for 700+ bacteria and fungi.

evvy.com
+5 more records
Core offering1 text field

Evvy sells direct-to-consumer at-home vaginal microbiome tests using metagenomic next-generation sequencing (mNGS) that screen 700+ bacteria and fungi from a single swab, plus companion diagnostics (UTI+ PCR Test), oral and vaginal probiotic supplements, and compounded prescription products (boric acid, hyaluronic acid, estradiol creams, suppositories). Results are clinician-reviewed and paired with personalized care plans, 1:1 coaching, eligibility for Rx treatment, and ongoing tracking through a quarterly membership subscription model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 100,000+ users supported
+8 more records
Product overview1 text field

Evvy operates as a single integrated precision women's health platform centered on the at-home Vaginal Health Test, which is augmented by optional add-ons (Expanded PCR Panel), companion diagnostics (UTI+ Test), daily supplements (Women's Complete Probiotic), targeted Rx products (Vaginal Probiotic Suppositories, Pure Boric Acid Suppositories, Hyaluronic Acid Suppositories, Estradiol Vaginal Cream, Anti-Itch Vulva Cream, Soothing Vulva Cream, Male Partner BV Treatment), a personalized Complete Treatment Program, and curated bundles (Vaginal Health & UTI+ Test Bundle, Women's Probiotic Bundle, Vaginal Health Test & Probiotic Bundle, Vaginal Health Test 2-Pack). The core test feeds a care platform that combines metagenomic sequencing, clinician review, and an Evvy Membership subscription model to deliver personalized insights, fertility and menopause support, BV subtyping, and prescription treatment pathways across vaginal symptoms, fertility, UTIs, and peri/menopause.

Product and service10 records
1Evvy Vaginal Health Test
CategoryAt-home diagnostic test
Description

CLIA/CAP/CLEP-certified at-home vaginal microbiome test using metagenomic sequencing (mNGS) to screen for 700+ bacteria and fungi from a single swab, returning clinician-reviewed results in 7-10 business days with a personalized care plan, 1:1 coaching, and optional Rx treatment eligibility. Priced at $159 one-time or $129/test on a quarterly Evvy Membership.

2Expanded PCR Panel (STI + PCR add-on)
CategoryAt-home diagnostic add-on
Description

Optional $89 add-on to the Vaginal Health Test that uses PCR to detect 4 STIs (chlamydia, gonorrhea, trich, Mycoplasma genitalium), 11 common microbes with microbial load, and 10 antibiotic resistance classes, with preliminary results in 1-3 business days.

3Evvy UTI+ Test
CategoryAt-home diagnostic test
Description

At-home PCR urine test that identifies 12 uropathogens and 7 antibiotic resistance genes with results in 1 business day, plus eligibility for same-day Rx pickup from an Evvy-affiliated provider. Priced at $248 one-time or $217.99 on a quarterly subscription.

4Women's Complete Probiotic
CategoryConsumer supplement (oral)
Description

Daily oral probiotic capsule formulated for 3-in-1 gut, urinary, and vaginal microbiome support, built on Evvy's proprietary blend (Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1, Lactobacillus crispatus LBV88, Lactobacillus acidophilus ProbioTec LA-5, Lactobacillus plantarum UALp-05) plus postbiotic tributyrin and vitamins D3 & E. Priced at $55 one-time or $44/month on subscription; 4.75B CFU at end of shelf life.

5Vaginal Probiotic Suppositories
CategoryRx product (vaginal suppository)
Description

Prescription vaginal suppositories delivering Evvy's multi-strain Lactobacillus blend (L. crispatus, GR-1/RC-14) plus lactoferrin and vitamin E directly to the vagina to restore pH and reduce odor/discharge. Compounded at a 503a NABP-accredited pharmacy; 20 suppositories for $59 one-time or $47.20 every 2 months.

6Pure Boric Acid Suppositories
CategoryRx product (vaginal suppository)
Description

Prescription-grade 600 mg boric acid vaginal suppositories compounded at a 503a NABP-accredited pharmacy to manage vaginal odor, pH imbalance, and recurrent symptoms. 12 suppositories for $39 one-time or $35.10 every 2 months on subscription.

7Hyaluronic Acid Suppositories
CategoryRx product (vaginal suppository)
Description

Prescription-grade hormone-free vaginal suppositories combining 5 mg hyaluronic acid with a moisturizing pH-balanced fatty-acid base for relief of dryness, itching, and painful sex in menopause, postpartum, or medication-induced dryness. 12 suppositories for $59 one-time or $53.10 every 2 months on subscription.

8Estradiol Vaginal Cream
CategoryRx product (vaginal cream)
Description

Paraben- and sulfate-free localized low-dose estradiol vaginal cream for menopausal dryness and related symptoms, part of Evvy's menopause-focused platform combining microbiome testing with hormone therapy. Priced at $69.

9Anti-Itch Vulva Cream
CategoryRx product (topical vulva cream)
Description

Rx topical vulva cream for quickly calming itching and irritation, available through Evvy's prescription symptom-relief line. Priced at $59.

10Soothing Vulva Cream
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMajor (Joint Awareness Campaign)TypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Joined Teal Health's joint awareness campaign with 30+ women-focused health companies to eliminate cervical cancer during Cervical Cancer Awareness Month (January 2026). Promotes FDA-authorized self-collection testing as alternative to traditional speculum exams.

Strategic tierModerate (Campaign Participant)TypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy and other women-focused health companies (January 2026).

Strategic tierModerate (Campaign Participant)TypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).

Strategic tierModerate (Campaign Participant)TypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).

Strategic tierModerate (Campaign Participant)TypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).

Strategic tierModerate (Campaign Participant)TypeGTM or Marketing PartnerAnnounced on2026-01-01
Description

Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).

Strategic tierMajor (Strategic Diagnostic Partner)TypeStrategic or Co-development Partner
Description

Labcorp logo is displayed prominently on Evvy's homepage alongside its venture fund. Labcorp Venture Fund participated in Evvy's $14M Series A, indicating a strategic diagnostic industry partnership supporting Evvy's lab services and testing infrastructure.

Strategic tierModerate (Payment Integration)TypeTechnology or Integration
Description

Evvy has partnered with TrueMed to streamline HSA/FSA payments for US customers. Users can choose 'TrueMed' as a payment method during checkout to complete HSA/FSA-eligible purchases.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Daye
TypeDirect peer
Description

UK-based femtech company that also offers at-home vaginal microbiome screening and CBD-based tampons/suppositories; directly comparable to Evvy as a DTC vaginal-health diagnostic and care brand targeting the same end consumer.

TypeDirect peer
Description

Virtual care clinic focused on perimenopause and menopause; directly comparable to Evvy's menopause workstream (Estradiol Vaginal Cream, Hyaluronic Acid Suppositories) and a co-marketing partner in Teal Health's cervical cancer campaign.

TypeBroad incumbent
Description

Premium DTC supplements and diagnostics brand; comparable to Evvy's Women's Complete Probiotic and broader at-home testing category, with overlapping premium positioning and HSA/FSA payment rails.

TypeDirect peer
Description

Virtual care platform for women's and family health (fertility, maternity, menopause); comparable to Evvy in target customer and adjacency to Evvy's fertility and menopause use cases, and a co-marketing partner in Teal Health's campaign.

TypeDirect peer
Description

DTC telehealth and prescription company for vaginal infections, UTIs, and herpes; competes with Evvy's UTI+ Test, Boric Acid Suppositories, and Hyaluronic Acid Suppositories in the same OTC/Rx women's health category.

6OVRY
TypeRegional player
Description

Canadian-based DTC women's health brand selling ovulation and vaginal-health products; comparable to Evvy as a femtech supplement and vaginal health brand with similar target customer, though regional to Canada.

TypeEmerging player
Description

Fertility-focused women's health company with at-home and clinic-based services; comparable to Evvy's fertility-journey customer segment and a co-marketing partner in Teal Health's cervical cancer campaign.

TypeEmerging player
Description

Women's health startup focused on at-home cervical cancer screening; comparable as a femtech DTC diagnostic adjacent to Evvy's STI/PCR panel and a current co-marketing partner.

TypeBroad incumbent
Description

Consumer wearable health platform (smart ring) with women's health features and a large individual user base; comparable to Evvy as a premium consumer health-data brand monetizing longitudinal personal health data.

TypeBroad incumbent
Description

Established telehealth provider for women's health (birth control, STI testing, HPV, UTI treatment); comparable to Evvy's telehealth + at-home test + Rx model and an established incumbent in DTC women's diagnostics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Evvy

Women's Health Diagnosticsevvy.com

Evvy is a New York-based precision women's health company that sells the first CLIA-certified metagenomic at-home vaginal microbiome test, plus companion diagnostics (UTI+), telehealth-prescribed Rx products, and probiotics, serving women with recurrent vaginal symptoms, fertility, menopause, and recurrent UTI needs.

What Evvy does

Evvy is a New York-based precision women's health company that operates a direct-to-consumer platform anchored by the first and only CLIA/CAP/CLEP-certified at-home vaginal microbiome test. The flagship test uses metagenomic next-generation sequencing (mNGS) on a single self-collected swab to screen 700+ bacteria and fungi—versus 1–3 pathogens in standard OB-GYN testing—and is processed in Evvy's CLIA-certified lab with clinician-reviewed results, a personalized care plan, optional Rx treatment, and a free 1:1 health coaching session. The underlying AI/molecular signature discovery platform is built on what the company describes as the world's largest vaginal microbiome dataset (100,000+ samples) and was used to identify six distinct microbial subtypes of bacterial vaginosis that have been integrated into the test report and care pathway.

The company has expanded beyond the core diagnostic into a vertically integrated care stack. Product lines now include the UTI+ PCR urine test (12 uropathogens, 7 antibiotic resistance genes, 1-day results), a Women's Complete Probiotic with Evvy's proprietary Lactobacillus blend plus postbiotic, prescription vaginal suppositories (probiotic, boric acid, hyaluronic acid), hormone-related Rx products (Estradiol Vaginal Cream, anti-itch and soothing vulva creams), a Male Partner BV Treatment regimen, the multi-step Evvy Complete Treatment Program, and curated bundles. All Rx products are compounded at a 503a NABP-accredited pharmacy and prescribed by Evvy-affiliated providers via asynchronous telehealth.

Evvy monetizes through a hybrid one-time purchase plus subscription model. The flagship Vaginal Health Test is priced at $159 one-time or $129/test on a quarterly Evvy Membership (4 tests/year); the UTI+ Test is $248 one-time or $217.99 on quarterly subscription; probiotics, suppositories, and creams are priced $39–$69 with Subscribe & Save options delivering 10–20% discounts. Bundles (up to $348) drive AOV. Primary customer segments are women with recurrent vaginal symptoms, women on the fertility journey, women in perimenopause/menopause, and women with recurrent UTIs, supplemented by a smaller segment of male partners of women with recurrent BV. Distribution is entirely D2C through evvy.com with US-dominant reach and limited Canada availability; no third-party retail or enterprise channel is in use.

Evvy firmographics

Firmographics
Name
Evvy
Legal name
Evvy
Website
https://evvy.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
Evvy is a New York-based precision women's health company that sells the first CLIA-certified metagenomic at-home vaginal microbiome test, plus companion diagnostics (UTI+), telehealth-prescribed Rx products, and probiotics, serving women with recurrent vaginal symptoms, fertility, menopause, and recurrent UTI needs.
Ownership category
akta.pro rank

Evvy industry classification

Industry
Product category
Women's Health Diagnostics
NAICS
Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Vaginal microbiome testing
  • At-home diagnostic tests
  • Women's health platform
  • Metagenomic sequencing services
  • Prescription telehealth care

Where Evvy is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Evvy business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. At-home Vaginal Health Test Sales: One-time and subscription sales of the flagship at-home Vaginal Microbiome Test at $159 one-time or $129/test on a quarterly membership (4 tests/year); includes Expanded PCR Panel add-on for +$89.
  2. Membership/Subscription Revenue: Recurring Evvy Membership billing quarterly with auto-refills, providing discounted tests, continuous tracking of microbiome changes, free coaching, and subscription savings (~$30 per test). Skip or cancel anytime.
  3. UTI+ Test Sales: One-time and subscription sales of the at-home UTI+ PCR urine test at $248 one-time or $217.99 on quarterly subscription; eligible customers can purchase targeted Rx treatment separately after results.
  4. Probiotic & Supplement Sales: Direct-to-consumer sales of Women's Complete Probiotic ($55 one-time or $44/month on Subscribe & Save with 20% off), Vaginal Probiotic Suppositories ($59 one-time or $47.20/every 2 months with 20% off).
  5. Prescription (Rx) Product Sales: Sales of compounded Rx products (Pure Boric Acid Suppositories $39, Hyaluronic Acid Suppositories $59, Estradiol Vaginal Cream $69, Anti-Itch Vulva Cream $59, Soothing Vulva Cream $59, Evvy Complete Treatment Program) prescribed by Evvy-affiliated providers, priced separately from tests and dispensed via 503a NABP-accredited pharmacy.
  6. Bundle Sales: Bundled product collections with 10-15% discounts: Vaginal Health & UTI+ Test Bundle ($348), Women's Probiotic Bundle ($97), Vaginal Health Test & Probiotic Bundle ($192.60), Vaginal Health Test 2-Pack ($258).

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEvvy Vaginal Health Test — single $159 or membership $129/test (quarterly)
SubscriptionAnnualEvvy UTI+ Test — single $248 or membership $217.99 (quarterly)
SubscriptionMonthlyWomen's Complete Probiotic — single $55 or monthly $44 subscription
SubscriptionPay-as-you-goVaginal Probiotic Suppositories — single $59 or every-2-months $47.20 subscription
SubscriptionPay-as-you-goPure Boric Acid Suppositories — single $39 or every-2-months $35.10 subscription
SubscriptionPay-as-you-goHyaluronic Acid Suppositories — single $59 or every-2-months $53.10 subscription
One time/ perpetual licensePay-as-you-goRx Creams and Estradiol Vaginal Cream — $59-$69 each
OtherPay-as-you-goBundled collections with 10-15% discounts from $97 to $348

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Evvy product offering

Product offering

Core offering

Evvy sells direct-to-consumer at-home vaginal microbiome tests using metagenomic next-generation sequencing (mNGS) that screen 700+ bacteria and fungi from a single swab, plus companion diagnostics (UTI+ PCR Test), oral and vaginal probiotic supplements, and compounded prescription products (boric acid, hyaluronic acid, estradiol creams, suppositories). Results are clinician-reviewed and paired with personalized care plans, 1:1 coaching, eligibility for Rx treatment, and ongoing tracking through a quarterly membership subscription model.

Product overview

Evvy operates as a single integrated precision women's health platform centered on the at-home Vaginal Health Test, which is augmented by optional add-ons (Expanded PCR Panel), companion diagnostics (UTI+ Test), daily supplements (Women's Complete Probiotic), targeted Rx products (Vaginal Probiotic Suppositories, Pure Boric Acid Suppositories, Hyaluronic Acid Suppositories, Estradiol Vaginal Cream, Anti-Itch Vulva Cream, Soothing Vulva Cream, Male Partner BV Treatment), a personalized Complete Treatment Program, and curated bundles (Vaginal Health & UTI+ Test Bundle, Women's Probiotic Bundle, Vaginal Health Test & Probiotic Bundle, Vaginal Health Test 2-Pack). The core test feeds a care platform that combines metagenomic sequencing, clinician review, and an Evvy Membership subscription model to deliver personalized insights, fertility and menopause support, BV subtyping, and prescription treatment pathways across vaginal symptoms, fertility, UTIs, and peri/menopause.

Differentiator

Problem solved

Functional benefit

Brands

  • Evvy Vaginal Health Test: Evvy's flagship at-home CLIA-certified, mNGS vaginal microbiome test that screens for 700+ bacteria and fungi.
  • Women's Complete Probiotic
  • Vaginal Probiotic Suppositories
  • UTI+ Test
  • Evvy Complete Treatment Program
  • Equal Research Day

Products and services

  • Evvy Vaginal Health Test CLIA/CAP/CLEP-certified at-home vaginal microbiome test using metagenomic sequencing (mNGS) to screen for 700+ bacteria and fungi from a single swab, returning clinician-reviewed results in 7-10 business days with a personalized care plan, 1:1 coaching, and optional Rx treatment eligibility. Priced at $159 one-time or $129/test on a quarterly Evvy Membership.
  • Expanded PCR Panel (STI + PCR add-on) Optional $89 add-on to the Vaginal Health Test that uses PCR to detect 4 STIs (chlamydia, gonorrhea, trich, Mycoplasma genitalium), 11 common microbes with microbial load, and 10 antibiotic resistance classes, with preliminary results in 1-3 business days.
  • Evvy UTI+ Test At-home PCR urine test that identifies 12 uropathogens and 7 antibiotic resistance genes with results in 1 business day, plus eligibility for same-day Rx pickup from an Evvy-affiliated provider. Priced at $248 one-time or $217.99 on a quarterly subscription.
  • Women's Complete Probiotic Daily oral probiotic capsule formulated for 3-in-1 gut, urinary, and vaginal microbiome support, built on Evvy's proprietary blend (Lactobacillus reuteri RC-14, Lactobacillus rhamnosus GR-1, Lactobacillus crispatus LBV88, Lactobacillus acidophilus ProbioTec LA-5, Lactobacillus plantarum UALp-05) plus postbiotic tributyrin and vitamins D3 & E. Priced at $55 one-time or $44/month on subscription; 4.75B CFU at end of shelf life.
  • Vaginal Probiotic Suppositories Prescription vaginal suppositories delivering Evvy's multi-strain Lactobacillus blend (L. crispatus, GR-1/RC-14) plus lactoferrin and vitamin E directly to the vagina to restore pH and reduce odor/discharge. Compounded at a 503a NABP-accredited pharmacy; 20 suppositories for $59 one-time or $47.20 every 2 months.
  • Pure Boric Acid Suppositories Prescription-grade 600 mg boric acid vaginal suppositories compounded at a 503a NABP-accredited pharmacy to manage vaginal odor, pH imbalance, and recurrent symptoms. 12 suppositories for $39 one-time or $35.10 every 2 months on subscription.
  • Hyaluronic Acid Suppositories Prescription-grade hormone-free vaginal suppositories combining 5 mg hyaluronic acid with a moisturizing pH-balanced fatty-acid base for relief of dryness, itching, and painful sex in menopause, postpartum, or medication-induced dryness. 12 suppositories for $59 one-time or $53.10 every 2 months on subscription.
  • Estradiol Vaginal Cream Paraben- and sulfate-free localized low-dose estradiol vaginal cream for menopausal dryness and related symptoms, part of Evvy's menopause-focused platform combining microbiome testing with hormone therapy. Priced at $69.
  • Anti-Itch Vulva Cream Rx topical vulva cream for quickly calming itching and irritation, available through Evvy's prescription symptom-relief line. Priced at $59.
  • Soothing Vulva Cream

Quantifiable outcome

  • 100,000+ users supported
  • +8 more outcomes

Companies that use Evvy

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Evvy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature7 records

Evvy partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered major (joint awareness campaign), moderate (campaign participant), major (strategic diagnostic partner) and moderate (payment integration).

  • Teal Healthmajor (joint awareness campaign)GTM or Marketing Partner · 1 January 2026Joined Teal Health's joint awareness campaign with 30+ women-focused health companies to eliminate cervical cancer during Cervical Cancer Awareness Month (January 2026). Promotes FDA-authorized self-collection testing as alternative to traditional speculum exams.
  • Midi Healthmoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy and other women-focused health companies (January 2026).
  • Maven Clinicmoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
  • Wispmoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
  • Kindbodymoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
  • The Flex Companymoderate (campaign participant)GTM or Marketing Partner · 1 January 2026Co-participant in Teal Health's joint cervical cancer awareness campaign alongside Evvy (January 2026).
  • Labcorpmajor (strategic diagnostic partner)Strategic or Co-development PartnerLabcorp logo is displayed prominently on Evvy's homepage alongside its venture fund. Labcorp Venture Fund participated in Evvy's $14M Series A, indicating a strategic diagnostic industry partnership supporting Evvy's lab services and testing infrastructure.
  • TrueMedmoderate (payment integration)Technology or IntegrationEvvy has partnered with TrueMed to streamline HSA/FSA payments for US customers. Users can choose 'TrueMed' as a payment method during checkout to complete HSA/FSA-eligible purchases.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Evvy competitors and assessment

Company assessment

Direct peers

  • Daye: UK-based femtech company that also offers at-home vaginal microbiome screening and CBD-based tampons/suppositories; directly comparable to Evvy as a DTC vaginal-health diagnostic and care brand targeting the same end consumer.
  • Midi Health: Virtual care clinic focused on perimenopause and menopause; directly comparable to Evvy's menopause workstream (Estradiol Vaginal Cream, Hyaluronic Acid Suppositories) and a co-marketing partner in Teal Health's cervical cancer campaign.
  • Maven Clinic: Virtual care platform for women's and family health (fertility, maternity, menopause); comparable to Evvy in target customer and adjacency to Evvy's fertility and menopause use cases, and a co-marketing partner in Teal Health's campaign.
  • Wisp: DTC telehealth and prescription company for vaginal infections, UTIs, and herpes; competes with Evvy's UTI+ Test, Boric Acid Suppositories, and Hyaluronic Acid Suppositories in the same OTC/Rx women's health category.

Broad incumbents

  • Thorne: Premium DTC supplements and diagnostics brand; comparable to Evvy's Women's Complete Probiotic and broader at-home testing category, with overlapping premium positioning and HSA/FSA payment rails.
  • Oura: Consumer wearable health platform (smart ring) with women's health features and a large individual user base; comparable to Evvy as a premium consumer health-data brand monetizing longitudinal personal health data.
  • Nurx: Established telehealth provider for women's health (birth control, STI testing, HPV, UTI treatment); comparable to Evvy's telehealth + at-home test + Rx model and an established incumbent in DTC women's diagnostics.

Regional players

  • OVRY: Canadian-based DTC women's health brand selling ovulation and vaginal-health products; comparable to Evvy as a femtech supplement and vaginal health brand with similar target customer, though regional to Canada.

Emerging players

  • Kindbody: Fertility-focused women's health company with at-home and clinic-based services; comparable to Evvy's fertility-journey customer segment and a co-marketing partner in Teal Health's cervical cancer campaign.
  • Teal Health: Women's health startup focused on at-home cervical cancer screening; comparable as a femtech DTC diagnostic adjacent to Evvy's STI/PCR panel and a current co-marketing partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Evvy social profiles

Digital presence

Evvy compliance and trust

Trust signal

Compliance6 records

Evvy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Evvy leadership team

Management profile

Number of profiles

Profiles4 records

Evvy funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Evvy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evvy

What does Evvy do?

Evvy sells direct-to-consumer at-home vaginal microbiome tests using metagenomic next-generation sequencing (mNGS) that screen 700+ bacteria and fungi from a single swab, plus companion diagnostics (UTI+ PCR Test), oral and vaginal probiotic supplements, and compounded prescription products (boric acid, hyaluronic acid, estradiol creams, suppositories). Results are clinician-reviewed and paired with personalized care plans, 1:1 coaching, eligibility for Rx treatment, and ongoing tracking through a quarterly membership subscription model.

Is Evvy a public or private company?

Evvy is a private company. It is classified as venture growth investor backed and is currently operating.

When was Evvy founded?

Evvy was founded in 2021. It employs 51 to 100 people.

Where is Evvy based?

Evvy is headquartered in New York, United States, in the North America region.

How does Evvy make money?

Six revenue lines are on record. At-home Vaginal Health Test Sales are the primary driver. The others are membership/Subscription Revenue, UTI+ Test Sales, probiotic & Supplement Sales, prescription (Rx) Product Sales and bundle Sales.

Who are Evvy's main competitors?

Direct peers on record are Daye, Midi Health, Maven Clinic and Wisp. Broad incumbents are Thorne, Oura and Nurx. OVRY is listed as a regional player. Emerging players are Kindbody and Teal Health.

Does Evvy have an API?

No public API is recorded for Evvy.

What industry is Evvy in?

Evvy's product category is Women's Health Diagnostics. Its primary akta.pro industry code is HLAGANAH, Microbiome & Metagenomics Services, with a secondary code of HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedCity NewsWhat’s Driving the Rise of Consumer Diagnostics?A panel at MedCity INVEST discussed drivers of consumer diagnostics, citing Covid-19, regulatory relaxations, and product-market fit. Panelists noted home testing became mainstream, with companies like 23andMe and Everlywell playing roles. Women's health diagnostics, such as Evvy's vaginal microbiome tests, were highlighted as an underserved area.AlleyWatchEvvy Raises $40M to Close the Gender Health Gap Starting with the Vaginal MicrobiomeEvvy raised a $40M Series B led by Catalio Capital, bringing total equity to $60M. The company offers a CLIA-certified metagenomic test for vaginal health, serving over 100,000 patients. It is now expanding into fertility, with a landmark IVF study wrapping up.AllureNow We're Supposed to Have a Forever-35 Vagina?Vaginal rejuvenation procedures and products are proliferating, targeting women from menarche through menopause. The American Society of Plastic Surgeons reported a 30% increase in vaginal rejuvenation procedures between 2005 and 2006, and a 2024 review notes a nearly 220% global rise in female genital plastic surgery over five years. Companies like Evvy have raised over $20 million for vaginal microbiome testing and care.AlleyWatch#NYCtech Week in Review: 9/14/26 – 9/20/26NYC startups raised funding across AI, fintech, and healthtech sectors, including Profound's $180M Series D and Stuut's $67.6M round. Other companies like Evvy, Highstock, and Rogo also secured funding, with total equity raised ranging from $5M to $344M.Digital Health NewsEvvy Raises $40Mn Series B to Advance AI-Powered Precision Diagnostics for Women’s HealthEvvy raised $40 million in a Series B round led by Catalio Capital Management to advance its AI-powered diagnostic and care models for women's health. The funding will support clinical validation, with fertility as an initial focus, and the platform has served over 100,000 patients and 3,000 practitioners.Medical BuyerEvvy raises USD 40M in Series B roundEvvy raised $40 million in Series B funding led by Catalio Capital Management. The company's AI diagnostics platform has served over 100,000 patients and reported a 50% reduction in bacterial vaginosis recurrence. It plans to expand into fertility diagnostics later this year.AlleyWatchThe AlleyWatch Startup Daily Funding Report: 9/16/2026Stuut raised $67.6M in Series B funding, Evvy raised $40M in Series B, Footprint raised $25M in Series B, and Tare raised $13.25M in seed funding. The rounds were led by various investors, with total funding for each company also disclosed.Medical Device NetworkEvvy secures $40m to validate AI-based women’s health diagnosticsEvvy raised $40m in a Series B round led by Catalio Capital to validate its AI-powered women's health diagnostics. The company has served over 100,000 patients and 3,000 practitioners, with funds supporting clinical validation and distribution, initially focusing on fertility.citybizEvvy Raises $40M Series B to Expand Precision Women’s Health PlatformEvvy raised $40 million in a Series B led by Catalio Capital Management. The funding supports its at-home vaginal microbiome test, which has supported 13 peer-reviewed publications and a 50% reduction in bacterial vaginosis recurrence. The company is developing EvvyAI, a machine-learning system for clinical decision-making.VC News DailyEvvy Secures $40M Series RoundEvvy, a women's health precision medicine company, raised an oversubscribed $40 million Series B led by Catalio Capital Management. The round includes new investors and existing backers, funding AI-driven diagnostic models starting with fertility. The company's Vaginal Health Test is CLIA-certified and CLEP-approved, uncovering 700+ microbes.